Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveResults31 Jul 2026

IDFC First Bank Ltd

Please find enclosed Earnings Call Transcript for the Q1 FY27

IDFC First Bank Ltd reported strong business momentum in Q1 FY27 with customer business crossing INR6 lakh crores and loan book growing 20.6% YoY to INR3.05 lakh crores. Retail, agri, and MSME book grew 18% YoY, while wholesale book grew 30%. Gross NPA ratio improved to 1.51% and net NPA ratio improved to 0.44%. Gross slippages reduced 2% QoQ and net slippages improved 4%.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults31 Jul 2026

IDFC First Bank Limited

Analysts/Institutional Investor Meet/Con. Call Updates

IDFC First Bank Limited has announced the transcript of its Q1 FY 2027 earnings call, highlighting strong business momentum, with customer business crossing INR6 lakh crores and loan book growing 20.6% YoY to INR3.05 lakh crores. The bank also reported improving asset quality, with gross NPA ratio decreasing to 1.51% and net NPA ratio decreasing to 0.44%.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults31 Jul 2026

Aptus Value Housing Finance India Ltd

Investor Press release for the Quarter ended on 31st June 2026

Aptus Value Housing Finance India Ltd has announced its financial results for the quarter ended June 30, 2026, with a 21% YoY growth in AUM, 36% YoY growth in disbursements, and 19% YoY growth in net income margin and net profit. The company has also expanded its presence in Maharashtra and Odisha, and plans to add 25 branches in Q2 FY27.

Read more →📎 1 attachment
BSEResult▲ PositiveResults31 Jul 2026

Voltamp Transformers Ltd

Unaudited Financial Result of the Company for the quarter ended June 30, 2026.

Voltamp Transformers Ltd announced unaudited financial results for the quarter ended June 30, 2026, with a fresh capital expenditure of INR 90 crores to build a new state-of-the-art facility for manufacturing dry-type transformers. The company's existing capacity utilization is 100% plus, and the proposed capacity addition is 2300 MVA, to be added within 12-14 months. The investment will be funded through internal accruals.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults31 Jul 2026

Aptus Value Housing Finance India Limited

Press Release

Aptus Value Housing Finance India Limited has announced its financial results for the quarter ended June 30, 2026, with a 21% year-over-year growth in AUM, 36% growth in disbursements, and 19% growth in net income margin and net profit.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults31 Jul 2026

Intellect Design Arena Ltd

Press Release on the Financial Results of Q1 for FY 27

Intellect Design Arena Ltd announced its Q1 FY27 results, with a 19% YoY revenue growth to INR 872 Cr, and LTM PBT crossing INR 500 Cr milestone. The company strengthened its product portfolio, expanded its addressable markets, and reinforced its AI capabilities through purpose-built platforms. It also launched new AI-first banking platforms, including eMACH.ai Islamic Banking and the Credit Union Solution Suite.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults31 Jul 2026

Intellect Design Arena Limited

Press Release

Intellect Design Arena Limited has announced its Q1 FY27 financial results, reporting a 19% YoY revenue growth to INR 872 Cr, with LTM PBT crossing INR 500 Cr milestone. The company has also announced the strategic carve-out of Purple Fabric as an independent Line of Business, and launched several new AI-first banking platforms.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults31 Jul 2026

IDFC First Bank Ltd

Please find enclosed Earnings call Transcript for Q1 FY27

IDFC First Bank Ltd announced its Q1 FY27 earnings conference call transcript, highlighting strong business momentum, with customer business crossing INR6 lakh crores, loan book growth of 20.6% YoY, and improving asset quality with gross NPA ratio further improving by 10 basis points to 1.51%.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults31 Jul 2026

IDFC First Bank Limited

Analysts/Institutional Investor Meet/Con. Call Updates

IDFC First Bank Limited has informed the Exchange about the transcript of the earnings call for the quarter ended June 30, 2026. The bank's customer business crossed INR6 lakh crores during the quarter, with a Y-o-Y increase of 20%. The loan book grew by 20.6% on a Y-o-Y basis, with the retail, agri, and MSME book growing by 18% and the wholesale book growing by 30%. The bank's asset quality improved, with the gross NPA ratio improving by 10 basis points to 1.51% and the net NPA ratio improving by 4 basis points to 0.44%. The bank's collection efficiency remained stable at 99.5%.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults31 Jul 2026

Shadowfax Technologies Limited

Investor Presentation

Shadowfax Technologies Limited has informed the Exchange about Investor Presentation for Q1 FY27, with the presentation containing forward-looking statements and highlighting the company's market share expansion, service portfolio, and quarterly growth pace.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults31 Jul 2026

Onesource Specialty Pharma Limited

Analysts/Institutional Investor Meet/Con. Call Updates

OneSource Specialty Pharma Limited has informed the Exchange about Earnings Call Transcript dated July 25, 2026. The company's CEO and MD, Neeraj Sharma, and CFO, Anurag Bhania, presented the key business and financial highlights for the quarter ended June 30, 2026. Revenues grew 37% year-on-year to INR4,490 million, driven by the semaglutide commercial launch, new MSA contracts, and new customer wins. EBITDA increased 39% year-on-year to INR1,233 million, with a sequential quarter-on-quarter growth of 34%. The company has made significant progress in its sema commercialization in Canada and has launched new products in India.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults31 Jul 2026

Strides Pharma Science Ltd

Earnings Presentation for the quarter ended June 30, 2026

Strides Pharma Science Ltd has announced its Q1FY27 earnings, with revenue growth of 13% YoY, and EBITDA growth of 5.4% YoY, despite a ₹131m impact on freight and operating costs from geopolitical disruptions. The company has also unlocked ₹1,000m of value through the divestment of its majority stake in Pivot Path, and improved its EcoVadis sustainability score to 68/100, a 19-point increase over last year.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults31 Jul 2026

Strides Pharma Science Ltd

Strides Delivers Steady Performance with Q1FY27; Revenue at Rs. 12,654m, Grew 13% YoY; Ex-US Markets Grew 17% YoY

Strides Pharma Science Ltd reported Q1FY27 results with revenue at ₹12,654m, a 13% YoY growth, driven by 17% YoY growth in Ex-US Markets. EBITDA grew 5.4% YoY to ₹2,298m, despite a ₹131m impact on operating costs from geopolitical disruptions. The company unlocked ₹1,000m of value through the divestment of its majority stake in Pivot Path, its captive GCC, while retaining meaningful participation in its future growth.

Read more →📎 1 attachment
NSEGeneral Updates▲ PositiveResults31 Jul 2026

Strides Pharma Science Limited

General Updates

Strides Pharma Science Limited has announced its Q1 FY 2027 earnings, with revenue growing 13% YoY to ₹12,654m, and EBITDA growing 5.4% YoY to ₹2,298m. The company has also divested its majority stake in Pivot Path, a captive GCC, and unlocked ₹1,000m of value. The company has improved its EcoVadis sustainability score to 68/100, a 19-point increase over last year.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults31 Jul 2026

Shadowfax Technologies Limited

Press Release

Shadowfax Technologies Limited has announced its Q1 FY27 financial results, with revenue growing 64.9% YoY to ₹1,358 Cr, Adjusted EBITDA margin expanding to 4.9%, and PAT reaching an all-time high of ₹65 Cr.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults31 Jul 2026

Strides Pharma Science Limited

Press Release

Strides Pharma Science Limited has announced its consolidated financial results for the quarter (Q1FY27) ended 30 June, 2026, with revenue at ₹12,654m, growing 13% YoY, and EBITDA at ₹2,298m, growing 5.4% YoY.

Read more →📎 1 attachment
← PreviousPage 451 of 537Next →